Africa (WHO region) vs Saudi Arabia: HIV-positive TB patients on ART (antiretroviral therapy)
Africa (WHO region)
96.0%
in 2024
Saudi Arabia
100.0%
in 2024
Africa (WHO region) rank
2nd
Saudi Arabia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Africa (WHO region)
- Saudi Arabia
How they compare
Saudi Arabia currently reports 100.0% against 96.0% in Africa (WHO region), a difference of 4.0%.
Across all 11 years both countries report, Saudi Arabia has been ahead every year.
Africa (WHO region) ranks 2nd and Saudi Arabia ranks 1st of 11 groups.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Africa (WHO region) | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30.0% | 100.0% | 70.0% | Saudi Arabia |
| 2010s | 90.0% | 99.0% | 9.0% | Saudi Arabia |
| 2020s | 93.2% | 100.0% | 6.8% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Africa (WHO region) or Saudi Arabia?
- Saudi Arabia, at 100.0% against 96.0% in Africa (WHO region) as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Africa (WHO region) and Saudi Arabia?
- 4.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for Africa (WHO region) and Saudi Arabia?
- 11 years are reported by both, from 2007 to 2024.
- How do Africa (WHO region) and Saudi Arabia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Africa (WHO region) ranks 2nd and Saudi Arabia ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.